Sharing successes, challenges and daily happenings in the Department of Medicine
ARTICLE: Atypical HUS may become a diagnosis of inclusion AUTHORS: J. Evan Sadler JOURNAL: Blood. 2015 Jun 4;125(23):3525-6. doi: 10.1182/blood-2015-04-640656 Patients with aHUS usually have… Read More »Atypical HUS may become a diagnosis of inclusion
On Wednesday, June 3, Mr. James Page, vice president and chief diversity officer for Johns Hopkins Medicine, gave an interactive discussion and presentation in order… Read More »Journeys in Medicine Implicit/Unconscious Bias
Many of our faculty and staff members have been asking about opportunities to volunteer in the community surrounding the East Baltimore campus. The Henderson-Hopkins school,… Read More »Community Volunteer Opportunities
To register, click here: http://www.jhsph.edu/academics/continuing-and-executive-education/johns-hopkins-institutes-of-public-health/summer-institutes/registration.html
At its annual meeting on Tuesday, June 2, the Maryland Hospital Association presented the Distinguished Service Award to the Ebola Response Team here at Johns… Read More »Ebola Response Team Earns MHA’s Distinguished Service Award
Sanofi and the Johns Hopkins School of Medicine will launch the Sanofi Innovation Awards (Sanofi iAwards) program, on Wednesday, June 10 from 5-6 p.m. in… Read More »Sanofi iAwards Program Initiative
The Association of American Medical Colleges will launch a new professional development program for mid-career minority faculty on September 18-19 at the Westin Buckhead Atlanta… Read More »Mid-Career Faculty Career Development Seminar
Roy Brower, professor in the Division of Pulmonary and Critical and Care Medicine, was recently awarded the Lifetime Achievement Award from the Critical Care Assembly… Read More »American Thoracic Society Awards
ARTICLE: Phosphorus-32, a Clinically Available Drug, Inhibits Cancer Growth by Inducing DNA Double-Strand Breakage AUTHOURS: Yulan Cheng, Ana P. Kiess, Joseph M. Herman, Martin G.… Read More »Phosphorus-32, a Clinically Available Drug, Inhibits Cancer Growth by Inducing DNA Double-Strand Breakage
Have an idea for a new patient safety program but not sure where to start? Employees within Johns Hopkins Medicine who want to develop their… Read More »Patient Safety and Quality Leadership Academy